3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Recruiting
2
Sponsor Class
OTHER
12
INDUSTRY
7
NIH
4
NETWORK
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
1
Gastrointestinal
1
Conditions
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Specimen Handling
16
Magnetic Resonance Spectroscopy
13
Vincristine
8
Dexamethasone
6
Cyclophosphamide
6
Radiotherapy
5
Radiation
5
Leucovorin
5
Lenalidomide
5
Doxorubicin
5
Cisplatin
5
Calcium Dobesilate
5
dexamethasone acetate
4
dexamethasone 21-phosphate
4
daratumumab
4
auricularum
4
X-Rays
4
Standard of Care
4
Radiotherapy, Conformal
4
Practice Guidelines as Topic
4
Etoposide
4
Cytarabine
4
Bortezomib
4
Biopsy
4
pegaspargase
3
Taxes
3
Radiotherapy, Intensity-Modulated
3
Radiosurgery
3
Prednisone
3
Platinum
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
NETWORK
×
cemiplimab
×
30 days
×
Clear all
NCT06931717
2026-06-01
ARCH
ETOP IBCSG Partners Foundation
Phase 3
Recruiting
390 enrolled
NCT07058012
2026-05-15
EMPIRE
NSABP Foundation Inc
Phase 2
Recruiting
79 enrolled